Genetic Vaccines and Therapy 1-
Tissue specific promoters improve specificity of AAV9 mediated
transgene expression following intra-vascular gene delivery in
Christina A Pacakt, Yoshihisa Sakait, Bijoy D Thattaliyath, Cathryn S Mah*
and Barry J Byrne*
Address: Powell Gene Therapy Center, College of Medicine, University of Florida, 1600 SW Archer Road, Gainesville, FL 32610-0266, USA
Email: Christina A Pacak firstname.lastname@example.org; Yoshihisa Sakai email@example.com; Bijoy D Thattaliyath firstname.lastname@example.org;
Cathryn S Mah* email@example.com; Barry J Byrne* firstname.lastname@example.org
* Corresponding authors tEqual contributors
Published: 4 February 2009
Genetic Vaccines and Therapy 2009, 7:3 doi:10.1 186/1479-0556-7-3
Received: 28 January 2009
Accepted: 4 February 2009
This article is available from: http://www.gvt-journal.com/content/7/l/3
2009 Pacak et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Since publication of our article , it has come to our
attention that the alpha-myosin heavy chain promoter
was incorrectly identified as being of human origin. The
correct origin of the promoter was from mouse.
The corrections within the text are as follows:
Under the heading Findings, 5 paragraph, line 3: "human
alpha-myosin heavy chain" should be "murine alpha-
myosin heavy chain."
Under the heading Findings, 8th paragraph, line 1: "The
human a-MHC promoter" should be "The murine a-MHC
Figure 1, Figure legend, line 6; "...created by amplifying
human genomic DNA" should be "... created by amplify-
ing mouse genomic DNA."
The authors regret the error and any inconveniences to the
readers. The results and conclusions of this article remain
I. Pacak CA, Sakai Y, Thattaliyath BD, Mah CS, Byrne BJ: Tissue spe-
cific promoters improve specificity ofAAV9 mediated trans-
gene expression following intra-vascular gene delivery in
neonatal mice. Genetic Vaccines and Therapy 2008, 6:13.
Page 1 of 1
(page number not for citation purposes)